InspireMD anticipates FDA approval of original CGuard delivery system in Q3 2026 as it withdraws 2026 revenue guidance
ORIGINAL SOURCE →via Seeking Alpha
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · conflict
- [CONFLICT] Intermodal Asia
- [CONFLICT] Securing the Untrusted Agentic Development Layer
- [CONFLICT] CHP’nin şaibeli kurultay davasında beşinci duruşma 6 Mayıs'ta
- [CONFLICT] Follow live: 76ers, Knicks in close contest in Eas...
- [CONFLICT] 24 haftalık doğum izni süreci başladı
- [CONFLICT] Bauchi marketers push for better trading spaces